20 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Guardion Health Sciences, Inc. GHSI shares rose 40.1% to $0.50 during Monday's pre-market session.
• Titan Pharmaceuticals, Inc. TTNP shares surged 34.5% to $0.35. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Novan, Inc. NOVN shares rose 13.4% to $0.95.
• SmileDirectClub, Inc. SDC shares moved upwards by 7.8% to $9.03. The most recent rating by Goldman Sachs, on December 18, is at Neutral, with a price target of $10.00.
• Cassava Sciences, Inc. SAVA shares moved upwards by 7.4% to $10.36.
• Achieve Life Sciences, Inc. ACHV stock increased by 6.9% to $0.59.
• Onconova Therapeutics, Inc. ONTX shares rose 6.8% to $0.52.
• Lipocine, Inc. LPCN stock surged 3.7% to $0.42.
• Microbot Medical, Inc. MBOT stock increased by 3.6% to $12.01. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
• Correvio Pharma, Inc. CORV stock moved upwards by 1.9% to $0.42. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
• Innate Pharma, Inc. IPHA shares moved upwards by 1.7% to $7.29.
• Biocept, Inc. BIOC stock surged 1.6% to $0.34.

Losers

• Leap Therapeutics, Inc. LPTX stock decreased by 9.3% to $1.46 during Monday's pre-market session. According to the most recent rating by Raymond James, on November 15, the current rating is at Market Perform.
• Ritter Pharmaceuticals, Inc. RTTR stock plummeted 3.4% to $0.21.
• Bionano Genomics, Inc. BNGO stock declined 2.4% to $1.20.
• Ocugen, Inc. OCGN shares fell 2.2% to $0.53. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
• Outlook Therapeutics, Inc. OTLK shares declined 2.0% to $1.00.
• Advaxis, Inc. ADXS stock decreased by 1.8% to $1.10.
• Teva Pharmaceutical Indus, Inc. TEVA stock decreased by 1.6% to $8.95. According to the most recent rating by JP Morgan, on November 12, the current rating is at Neutral.
• Qiagen, Inc. QGEN stock fell 1.3% to $33.50. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.